Brief: Aquestive Therapeutics Reports Q3 Results And Raises 2019 Guidance
05/11/2019 22:45
Nov 5 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* AQUESTIVE THERAPEUTICS REPORTS THIRD QUARTER 2019
FINANCIAL
RESULTS AND RAISES 2019 GUIDANCE
* Q3 REVENUE $12.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$10
MILLION
* SEES FY 2019 REVENUE $45 MILLION TO $47 MILLION
* Q3 LOSS PER SHARE $0.74
* Q3 EARNINGS PER SHARE ESTIMATE $-0.69 -- REFINITIV IBES
DATA
* SEES 2019 NON-GAAP ADJUSTED EBITDA LOSS OF $49 MILLION TO
$50
MILLION
* CASH & CASH EQUIVALENTS AS OF SEPTEMBER 30, 2019 WERE
$20.9
MILLION
Source text for Eikon: ID:nGNX9xRyMr
Further company coverage: AQST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allon Therapeutics
See all newsBrief: Aquestive Therapeutics Receives FDA Response To Citizen’S Petition
Brief: Aquestive Therapeutics Exceeds Top End Of Guidance Range For Preliminary Unaudited Full Year 2019 Total Revenues And Provides Initial Full Year 2020 Guidance
Brief: Aquestive Therapeutics Announces Pricing Of Public Offering Of Common Stock
Brief: Aquestive Therapeutics Announces Proposed Public Offering Of $35 Mln Shares Of Common Stock
Brief: Aquestive Therapeutics Reports Q3 Results And Raises 2019 Guidance